Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Arance

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 10, 2000
Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancerX Garcia del Muro, A Torregrosa, J Muñoz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 23, 2019
A retrospective chart review study describing metastatic melanoma patients profile and treatment patterns in SpainI Márquez-Rodas, A Arance, A Berrocal, et al.
Cancer|August 16, 2001
Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinomaS C White, P Lorigan, M R Middleton, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 17, 2015
SEOM guidelines for the management of Malignant Melanoma 2015A Berrocal, A Arance, E Espinosa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2020
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)M Majem, E García-Martínez, M Martinez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 9, 2017
SEOM clinical guideline for the management of malignant melanoma (2017)A Berrocal, A Arance, V E Castellon, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 17, 2013
Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyS Martín-Algarra, M T Fernández-Figueras, J A López-Martín, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2021
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trialB G M Hughes, E Munoz-Couselo, L Mortier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre studyG A McArthur, M Maio, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2020
Cobimetinib plus atezolizumab in BRAF<sup>V600</sup> wild-type melanoma: primary results from the randomized phase III IMspire170 studyH Gogas, B Dréno, J Larkin, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|March 10, 2000
Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancerX Garcia del Muro, A Torregrosa, J Muñoz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 23, 2019
A retrospective chart review study describing metastatic melanoma patients profile and treatment patterns in SpainI Márquez-Rodas, A Arance, A Berrocal, et al.
Cancer|August 16, 2001
Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinomaS C White, P Lorigan, M R Middleton, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 17, 2015
SEOM guidelines for the management of Malignant Melanoma 2015A Berrocal, A Arance, E Espinosa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2020
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)M Majem, E García-Martínez, M Martinez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 9, 2017
SEOM clinical guideline for the management of malignant melanoma (2017)A Berrocal, A Arance, V E Castellon, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 17, 2013
Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyS Martín-Algarra, M T Fernández-Figueras, J A López-Martín, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2021
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trialB G M Hughes, E Munoz-Couselo, L Mortier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre studyG A McArthur, M Maio, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2020
Cobimetinib plus atezolizumab in BRAF<sup>V600</sup> wild-type melanoma: primary results from the randomized phase III IMspire170 studyH Gogas, B Dréno, J Larkin, et al.
Pageof 4